Physician profile
Kevin Kumar Patel
NPI 1609066216
$4,369.40
in general payments reported to CMS, 2019-2025
11 companies · $3,824 in 2025
The $3,824 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2021: $67.79 · 2022: $54.79 · 2023: $64.87 · 2024: $218 · 2025: $3,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,460 · Food and Beverage: $629 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,460.16 |
| Food and Beverage | $629.32 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $3,824.26 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $124.93 | 2024 | Onivyde |
| Comsort, INC | $100.00 | 2019 | |
| Merck Sharp & Dohme LLC | $97.38 | 2021-2024 | Welireg |
| Kedrion Biopharma, INC. | $63.52 | 2023-2024 | Kedrab, Gammaked, Koate |
| Pfizer INC. | $41.43 | 2019-2021 | |
| Becton, Dickinson and Company | $28.47 | 2021 | |
| Octapharma USA, INC. | $27.46 | 2024 | Balfaxar |
| Daiichi Sankyo INC. | $26.53 | 2023 | Enhertu |
| Abbvie INC. | $22.78 | 2024 | |
| Genentech USA, INC. | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.